The researchers found that tumors expressing STAG2 as a biomarker are twice as likely to recur and progress toward muscle invasion and metastasis.
Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.
The company presented three posters at AACR, two of which demonstrated insights from its circulating DNA monitoring in colorectal and bladder cancers.
A Nature Human Behaviour study finds that when women are paper authors, medical articles are more likely to include analysis by gender and sex.
Researchers at Aarhus will use Natera's liquid biopsy assay to monitor colorectal cancer patients after surgery and chemotherapy.
Denmark-based Arcedi would like to commercialize its technology through a major diagnostic company.
Natera said that this research collaboration and others will help it clinically validate its circulating tumor DNA assay Signatera.
Scientists reported this week for the first time a Danish reference genome based on the de novo assembly of 150 genomes from 50 family trios.
The new data center will establish a strong foundation for research into the genetic causes of common diseases and how to prevent them.
The projects focus on early treatment of prostate cancer and cataloguing mutations in difficult-to-diagnose diseases, among other things.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.